High plasma homocysteine: A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles

Kandice Kottke-Marchant, Ralph Green, Donald W. Jacobsen, Anjan Gupta, Susan R. Savon, Michelle Secic, Killian Robinson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A high plasma homocysteine concentration is associated with premature vascular disease and thrombosis. The association between high homocysteine concentrations and thrombosis in patients with a normal coagulation profile is unknown. Sixty adults (37 men and 23 women, mean age 46 years) with documented thrombosis were compared with age- and sex-matched controls. Those with risk factors for thrombosis or abnormal coagulation profiles were excluded. Homocysteine concentrations were higher in cases than controls (21.8 ± 13.8 vs 11.0 ± 4.7 μmol/L, p < 0.001). A cut point for defining high homocysteine concentrations was determined at 13 μmol/L and conferred an increased odds ratio for thrombosis overall (7.8, 95% CI 3.0-20.2, p < 0.001) as well as in men (8.9, 95% CI 3.026.1; p < 0.001) and women (37.8, 95% CI 6.5-213.9; p < 0.01). A high plasma homocysteine is a risk factor for thrombosis in patients with a normal coagulation profile. This common abnormality should be sought in patients with otherwise unexplained thrombotic episodes.

Original languageEnglish (US)
Pages (from-to)239-244
Number of pages6
JournalClinical and Applied Thrombosis/Hemostasis
Volume3
Issue number4
StatePublished - Oct 1997
Externally publishedYes

Fingerprint

Homocysteine
Venous Thrombosis
Thrombosis
Vascular Diseases
Odds Ratio

Keywords

  • Clotting
  • Homocysteine
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Kottke-Marchant, K., Green, R., Jacobsen, D. W., Gupta, A., Savon, S. R., Secic, M., & Robinson, K. (1997). High plasma homocysteine: A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles. Clinical and Applied Thrombosis/Hemostasis, 3(4), 239-244.

High plasma homocysteine : A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles. / Kottke-Marchant, Kandice; Green, Ralph; Jacobsen, Donald W.; Gupta, Anjan; Savon, Susan R.; Secic, Michelle; Robinson, Killian.

In: Clinical and Applied Thrombosis/Hemostasis, Vol. 3, No. 4, 10.1997, p. 239-244.

Research output: Contribution to journalArticle

Kottke-Marchant, K, Green, R, Jacobsen, DW, Gupta, A, Savon, SR, Secic, M & Robinson, K 1997, 'High plasma homocysteine: A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles', Clinical and Applied Thrombosis/Hemostasis, vol. 3, no. 4, pp. 239-244.
Kottke-Marchant, Kandice ; Green, Ralph ; Jacobsen, Donald W. ; Gupta, Anjan ; Savon, Susan R. ; Secic, Michelle ; Robinson, Killian. / High plasma homocysteine : A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles. In: Clinical and Applied Thrombosis/Hemostasis. 1997 ; Vol. 3, No. 4. pp. 239-244.
@article{2e9fe7c28fc24d20951a767f52c130b4,
title = "High plasma homocysteine: A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles",
abstract = "A high plasma homocysteine concentration is associated with premature vascular disease and thrombosis. The association between high homocysteine concentrations and thrombosis in patients with a normal coagulation profile is unknown. Sixty adults (37 men and 23 women, mean age 46 years) with documented thrombosis were compared with age- and sex-matched controls. Those with risk factors for thrombosis or abnormal coagulation profiles were excluded. Homocysteine concentrations were higher in cases than controls (21.8 ± 13.8 vs 11.0 ± 4.7 μmol/L, p < 0.001). A cut point for defining high homocysteine concentrations was determined at 13 μmol/L and conferred an increased odds ratio for thrombosis overall (7.8, 95{\%} CI 3.0-20.2, p < 0.001) as well as in men (8.9, 95{\%} CI 3.026.1; p < 0.001) and women (37.8, 95{\%} CI 6.5-213.9; p < 0.01). A high plasma homocysteine is a risk factor for thrombosis in patients with a normal coagulation profile. This common abnormality should be sought in patients with otherwise unexplained thrombotic episodes.",
keywords = "Clotting, Homocysteine, Thrombosis",
author = "Kandice Kottke-Marchant and Ralph Green and Jacobsen, {Donald W.} and Anjan Gupta and Savon, {Susan R.} and Michelle Secic and Killian Robinson",
year = "1997",
month = "10",
language = "English (US)",
volume = "3",
pages = "239--244",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - High plasma homocysteine

T2 - A risk factor for arterial and venous thrombosis in patients with normal coagulation profiles

AU - Kottke-Marchant, Kandice

AU - Green, Ralph

AU - Jacobsen, Donald W.

AU - Gupta, Anjan

AU - Savon, Susan R.

AU - Secic, Michelle

AU - Robinson, Killian

PY - 1997/10

Y1 - 1997/10

N2 - A high plasma homocysteine concentration is associated with premature vascular disease and thrombosis. The association between high homocysteine concentrations and thrombosis in patients with a normal coagulation profile is unknown. Sixty adults (37 men and 23 women, mean age 46 years) with documented thrombosis were compared with age- and sex-matched controls. Those with risk factors for thrombosis or abnormal coagulation profiles were excluded. Homocysteine concentrations were higher in cases than controls (21.8 ± 13.8 vs 11.0 ± 4.7 μmol/L, p < 0.001). A cut point for defining high homocysteine concentrations was determined at 13 μmol/L and conferred an increased odds ratio for thrombosis overall (7.8, 95% CI 3.0-20.2, p < 0.001) as well as in men (8.9, 95% CI 3.026.1; p < 0.001) and women (37.8, 95% CI 6.5-213.9; p < 0.01). A high plasma homocysteine is a risk factor for thrombosis in patients with a normal coagulation profile. This common abnormality should be sought in patients with otherwise unexplained thrombotic episodes.

AB - A high plasma homocysteine concentration is associated with premature vascular disease and thrombosis. The association between high homocysteine concentrations and thrombosis in patients with a normal coagulation profile is unknown. Sixty adults (37 men and 23 women, mean age 46 years) with documented thrombosis were compared with age- and sex-matched controls. Those with risk factors for thrombosis or abnormal coagulation profiles were excluded. Homocysteine concentrations were higher in cases than controls (21.8 ± 13.8 vs 11.0 ± 4.7 μmol/L, p < 0.001). A cut point for defining high homocysteine concentrations was determined at 13 μmol/L and conferred an increased odds ratio for thrombosis overall (7.8, 95% CI 3.0-20.2, p < 0.001) as well as in men (8.9, 95% CI 3.026.1; p < 0.001) and women (37.8, 95% CI 6.5-213.9; p < 0.01). A high plasma homocysteine is a risk factor for thrombosis in patients with a normal coagulation profile. This common abnormality should be sought in patients with otherwise unexplained thrombotic episodes.

KW - Clotting

KW - Homocysteine

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0031426012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031426012&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031426012

VL - 3

SP - 239

EP - 244

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

IS - 4

ER -